etidronate sodium Capsules 200 mg, 300 mg, 400 mg
Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
Vietnam
Available for
Distribution only
Manufacturer #2110
A pharmaceutical manufacturer based in the EU that has been active for 50+ years.
The company's production lines are GMP-compliant.
Key production lines are Rx and OTC.
Main therapeutic areas include the cardiovascular system, CNS, and diabetes.
Main dosage forms include solid, liquid, semi-solid and injectable forms.
Manufacturer usually replies in 6 days